메뉴 건너뛰기




Volumn 70, Issue 1, 2010, Pages 99-108

Milnacipran: In fibromyalgia

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOMIPRAMINE; DIGOXIN; FLUOXETINE; LITHIUM; LORAZEPAM; MILNACIPRAN; MONOAMINE OXIDASE INHIBITOR; SAVELLA; UNCLASSIFIED DRUG; WARFARIN;

EID: 73349114903     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11202810-000000000-00000     Document Type: Review
Times cited : (12)

References (35)
  • 1
    • 38049165722 scopus 로고    scopus 로고
    • American College of Rheumatology [online] [Accessed 2009 Jul 29]
    • American College of Rheumatology. Fibromyalgia (fact sheet) [online]. Available from URL: http://www.rheumatology. org/public/factsheets/diseases-and- conditions/fibromyalgia. pdf [Accessed 2009 Jul 29]
    • Fibromyalgia (Fact Sheet)
  • 2
    • 68849104318 scopus 로고    scopus 로고
    • Fibromyalgia: A complex syndrome requiring a multidisciplinary approach
    • Spaeth M, Briley M. Fibromyalgia: a complex syndrome requiring a multidisciplinary approach. Hum Psycho-pharmacol Clin Exp 2009; 24 Suppl.: S3-10
    • (2009) Hum Psycho-pharmacol Clin Exp , vol.24 , Issue.SUPPL.
    • Spaeth, M.1    Briley, M.2
  • 3
    • 0025266660 scopus 로고
    • The American College of Rheumatology 1990 criteria for the classification of fibromyalgia
    • Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33 (2): 160-172
    • (1990) Arthritis Rheum , vol.33 , Issue.2 , pp. 160-172
    • Wolfe, F.1    Smythe, H.A.2    Yunus, M.B.3
  • 4
    • 31044442025 scopus 로고    scopus 로고
    • Fibromyalgia diagnosis: A comparison of clinical, survey, and American College of Rheumatology criteria
    • Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006; 54 (1): 169-176
    • (2006) Arthritis Rheum , vol.54 , Issue.1 , pp. 169-176
    • Katz, R.S.1    Wolfe, F.2    Michaud, K.3
  • 5
    • 60249084829 scopus 로고    scopus 로고
    • Treatment options and patient perspectives in the management of fibromyalgia: Future trends
    • Lawson K. Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuro-psych Dis Treat 2008; 4 (6): 1059-1071
    • (2008) Neuro-psych Dis Treat , vol.4 , Issue.6 , pp. 1059-1071
    • Lawson, K.1
  • 6
    • 68849093756 scopus 로고    scopus 로고
    • Fibromyalgia: Pathways and neurotransmitters
    • Stahl SM. Fibromyalgia: pathways and neurotransmitters. Hum Psychopharmacol Clin Exp 2009; 24 Suppl.: S11-7
    • (2009) Hum Psychopharmacol Clin Exp , vol.24 , Issue.SUPPL.
    • Stahl, S.M.1
  • 8
    • 53549087538 scopus 로고    scopus 로고
    • Pregabalin: A review of its use in fibromyalgia
    • Lyseng-Williamson KA, Siddiqui MA. Pregabalin: a review of its use in fibromyalgia. Drugs 2008; 68 (15): 2205-2223
    • (2008) Drugs , vol.68 , Issue.15 , pp. 2205-2223
    • Lyseng-Williamson, K.A.1    Siddiqui, M.A.2
  • 9
    • 67649356935 scopus 로고    scopus 로고
    • Duloxetine: In patients with fibromyalgia
    • Curran MP. Duloxetine: in patients with fibromyalgia. Drugs 2009; 69 (9): 1217-1227
    • (2009) Drugs , vol.69 , Issue.9 , pp. 1217-1227
    • Curran, M.P.1
  • 10
  • 11
    • 0031661167 scopus 로고    scopus 로고
    • Milnacipran: A review of its use in depression
    • Sep
    • Spencer CM, Wilde MI. Milnacipran: a review of its use in depression. Drugs 1998 Sep; 56 (3): 405-427
    • (1998) Drugs , vol.56 , Issue.3 , pp. 405-427
    • Spencer, C.M.1    Wilde, M.I.2
  • 12
    • 0022401405 scopus 로고
    • Biochemical profile of midalcipran (F2207), 1-phenyl-1-diethyl- aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug
    • Moret C, Charveron M, Finberg JP, et al. Biochemical profile of midalcipran (F2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology 1985; 24 (12): 1211-1219
    • (1985) Neuropharmacology , vol.24 , Issue.12 , pp. 1211-1219
    • Moret, C.1    Charveron, M.2    Finberg, J.P.3    Al, E.4
  • 13
    • 0033972686 scopus 로고    scopus 로고
    • Pharmaco-dynamics of milnacipran in young and elderly volunteers
    • Feb
    • Hindmarch I, Rigney U, Stanley N, et al. Pharmaco-dynamics of milnacipran in young and elderly volunteers. Br J Clin Pharmacol 2000 Feb; 49: 118-125
    • (2000) Br J Clin Pharmacol , vol.49 , pp. 118-125
    • Hindmarch, I.1    Rigney, U.2    Stanley, N.3
  • 14
    • 0742324808 scopus 로고    scopus 로고
    • Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers
    • Poirier MF, Galinowski A, Amado I, et al. Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers. Hum Psychopharmacol Clin Exp 2004; 19: 1-7
    • (2004) Hum Psychopharmacol Clin Exp , vol.19 , pp. 1-7
    • Poirier, M.F.1    Galinowski, A.2    Amado, I.3
  • 15
    • 0027745755 scopus 로고
    • Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent
    • Dec
    • Caron J, Libersa C, Hazard JR, et al. Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent. Eur Neuropsychopharmacol 1993 Dec; 3: 493-500
    • (1993) Eur Neuropsychopharmacol , vol.3 , pp. 493-500
    • Caron, J.1    Libersa, C.2    Hazard, J.R.3
  • 16
    • 73349124243 scopus 로고    scopus 로고
    • Precuneus contrast distinguishes milnacipran from placebo: An fMRI study in fibromyalgia patients
    • [abstract no. 857.19/HH2]. Presented at the Nov 15-19; Washington, DC
    • Ingvar M, Petzke F, Marcus H, et al. Precuneus contrast distinguishes milnacipran from placebo: an fMRI study in fibromyalgia patients [abstract no. 857.19/HH2]. Presented at the 38th Annual Meeting for the Society for Neuro-science; 2008 Nov 15-19; Washington, DC
    • (2008) 38th Annual Meeting for the Society for Neuro-science
    • Ingvar, M.1    Petzke, F.2    Marcus, H.3
  • 17
    • 73349096343 scopus 로고    scopus 로고
    • Milnacipran: Beyond a role of antidepressant
    • Pae C-U, Marks DM, Shah M, et al. Milnacipran: beyond a role of antidepressant. Clin Neuropharmacol 2009; 32 (6): 355-363
    • (2009) Clin Neuropharmacol , vol.32 , Issue.6 , pp. 355-363
    • Pae, C.-U.1    Marks, D.M.2    Shah, M.3
  • 18
    • 68849113241 scopus 로고    scopus 로고
    • Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran
    • Mainguy Y. Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran. Hum Psychopharmacol Clin Exp 2009; 24 Suppl.: S19-23
    • (2009) Hum Psychopharmacol Clin Exp , vol.24 , Issue.SUPPL.
    • Mainguy, Y.1
  • 19
    • 6344285317 scopus 로고    scopus 로고
    • Serotonin and noradrenaline reuptake inhibitors in animal models of pain
    • Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol Clin Exp 2004; 19 Suppl.: S15-9
    • (2004) Hum Psychopharmacol Clin Exp , vol.19 , Issue.SUPPL.
    • Mochizucki, D.1
  • 20
    • 73349111687 scopus 로고    scopus 로고
    • Milnacipran's effect on body weight by baseline BMI: Results across 3 randomized, double-blind, placebo-controlled fibromyalgia trials
    • Presented at the Oct 17-21; Philadelphia (PA)
    • Arnold LM, Palmer RH, Hufford MR, et al. Milnacipran's effect on body weight by baseline BMI: results across 3 randomized, double-blind, placebo-controlled fibromyalgia trials. Presented at the 73rd Annual American College of Rheumatology Meeting; 2009 Oct 17-21; Philadelphia (PA)
    • (2009) 73rd Annual American College of Rheumatology Meeting
    • Arnold, L.M.1    Palmer, R.H.2    Hufford, M.R.3
  • 21
    • 64849117499 scopus 로고    scopus 로고
    • The efficacy and safety of milnacipran for treatment of fibromyalgia: A randomized, double-blind, placebo-controlled trial
    • Feb
    • Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009 Feb; 36 (2): 398-409
    • (2009) J Rheumatol , vol.36 , Issue.2 , pp. 398-409
    • Mease, P.J.1    Clauw, D.J.2    Gendreau, R.M.3
  • 22
    • 57649234533 scopus 로고    scopus 로고
    • Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
    • Nov
    • Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008 Nov; 30 (11): 1988-2004
    • (2008) Clin Ther , vol.30 , Issue.11 , pp. 1988-2004
    • Clauw, D.J.1    Mease, P.2    Palmer, R.H.3
  • 23
    • 73349106575 scopus 로고    scopus 로고
    • Milnacipran 100mg/day in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled trial
    • Poster presented at the Oct 16-21; Philadelphia (PA)
    • Arnold LM, Gendreau RM, Spera A, et al. Milnacipran 100mg/day in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. Poster presented at the 73rd Annual Scientific American College of Rheumatology Meeting; 2009 Oct 16-21; Philadelphia (PA)
    • (2009) 73rd Annual Scientific American College of Rheumatology Meeting
    • Arnold, L.M.1    Gendreau, R.M.2    Spera, A.3
  • 24
    • 70349300638 scopus 로고    scopus 로고
    • In vitro inhibition and induction of human liver cytochrome P450 enzymes by milnacipran
    • Paris BL, Ogilvie BW, Scheinkienig JA, et al. In vitro inhibition and induction of human liver cytochrome P450 enzymes by milnacipran. Drug Metab Disp 2009; 37 (10): 2045-2054
    • (2009) Drug Metab Disp , vol.37 , Issue.10 , pp. 2045-2054
    • Paris, B.L.1    Ogilvie, B.W.2    Scheinkienig, J.A.3    Al, E.4
  • 26
    • 0000019544 scopus 로고
    • Plasma levels of F 2207, midalcipran, a novel antidepressant, after single oral administration in volunteers
    • Puozzo C, Filaquier C, Briley M. Plasma levels of F 2207, midalcipran, a novel antidepressant, after single oral administration in volunteers. Br J Clin Pharmacol 1985; 20: 291P
    • (1985) Br J Clin Pharmacol , vol.20
    • Puozzo, C.1    Filaquier, C.2    Briley, M.3
  • 27
    • 0029827287 scopus 로고    scopus 로고
    • Pharmacokinetics of milnacipran in comparison with other antidepressants
    • Sep
    • Puozzo C, Leonard BE. Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psycho-pharmacol 1996 Sep; 11 (Suppl. 4): 15-27
    • (1996) Int Clin Psycho-pharmacol , vol.11 , Issue.SUPPL. 4 , pp. 15-27
    • Puozzo, C.1    Leonard, B.E.2
  • 28
    • 24344447705 scopus 로고    scopus 로고
    • Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants
    • Puozzo C, Lens S, Reh C, et al. Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants. Clin Phar-macokinet 2005; 44 (9): 977-988
    • (2005) Clin Phar-macokinet , vol.44 , Issue.9 , pp. 977-988
    • Puozzo, C.1    Lens, S.2    Reh, C.3
  • 29
    • 70349727760 scopus 로고    scopus 로고
    • Milnacipran for the treatment of fibromyalgia syndrome: A European multicenter, double-blind, placebo-controlled trial
    • [abstract no. P.8.a.014] Aug
    • Branco J, Bragee G, Zachrisson O, et al. Milnacipran for the treatment of fibromyalgia syndrome: a European multicenter, double-blind, placebo-controlled trial [abstract no. P.8.a.014]. Eur Neuropsychopharmacol 2008 Aug; 18 Suppl. 4: S574-5
    • (2008) Eur Neuropsychopharmacol , vol.18 , Issue.SUPPL. 4
    • Branco, J.1    Bragee, G.2    Zachrisson, O.3
  • 31
    • 6344231258 scopus 로고    scopus 로고
    • A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    • Oct
    • Vitton O, Gendreau M, Gendreau J, et al. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004 Oct; 19 Suppl. 1: S27-35
    • (2004) Hum Psychopharmacol , vol.19 , Issue.SUPPL. 1
    • Vitton, O.1    Gendreau, M.2    Gendreau, J.3
  • 32
    • 26444518188 scopus 로고    scopus 로고
    • Efficacy of milnacipran in patients with fibromyalgia
    • Oct
    • Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005 Oct; 32 (10): 1975-1985
    • (2005) J Rheumatol , vol.32 , Issue.10 , pp. 1975-1985
    • Gendreau, R.M.1    Thorn, M.D.2    Gendreau, J.F.3
  • 33
    • 1542514939 scopus 로고    scopus 로고
    • An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms
    • Nagaoka S, Ohno M, Sekiguchi A. An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms. Int JPsych Clin Pract 2004; 8 (1): 47-51
    • (2004) Int JPsych Clin Pract , vol.8 , Issue.1 , pp. 47-51
    • Nagaoka, S.1    Ohno, M.2    Sekiguchi, A.3
  • 34
    • 33644807054 scopus 로고    scopus 로고
    • The fibromyalgia impact questionnaire (FIQ): A review of its development, current version, operating characteristics and uses
    • Bennett R. The fibromyalgia impact questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23 Suppl. 39: S154-62
    • (2005) Clin Exp Rheumatol , vol.23 , Issue.SUPPL. 39
    • Bennett, R.1
  • 35
    • 70349349593 scopus 로고    scopus 로고
    • Improvements in fibro-myalgia symptoms are sustained for 1 year with milnacipran treatment: Results from a dose-controlled, extension study
    • [abstract no. 583]
    • Mease P, Palmer RH, Rao S, et al. Improvements in fibro-myalgia symptoms are sustained for 1 year with milnacipran treatment: results from a dose-controlled, extension study [abstract no. 583]. Arthritis Rheum 2008; 58 (9 Suppl.): S383
    • (2008) Arthritis Rheum , vol.58 , Issue.9 SUPPL.
    • Mease, P.1    Palmer, R.H.2    Rao, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.